Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Global ubiquitination analysis reveals extensive modification and proteasomal degradation of cowpox virus proteins, but preservation of viral cores.

Grossegesse M, Doellinger J, Fritsch A, Laue M, Piesker J, Schaade L, Nitsche A.

Sci Rep. 2018 Jan 29;8(1):1807. doi: 10.1038/s41598-018-20130-9.

2.

Combined Proteomics/Genomics Approach Reveals Proteomic Changes of Mature Virions as a Novel Poxvirus Adaptation Mechanism.

Grossegesse M, Doellinger J, Tyshaieva A, Schaade L, Nitsche A.

Viruses. 2017 Nov 10;9(11). pii: E337. doi: 10.3390/v9110337.

3.

A Next-Generation Sequencing Approach Uncovers Viral Transcripts Incorporated in Poxvirus Virions.

Grossegesse M, Doellinger J, Haldemann B, Schaade L, Nitsche A.

Viruses. 2017 Oct 13;9(10). pii: E296. doi: 10.3390/v9100296.

4.

Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016.

Lehmann C, Kochanek M, Abdulla D, Becker S, Böll B, Bunte A, Cadar D, Dormann A, Eickmann M, Emmerich P, Feldt T, Frank C, Fries J, Gabriel M, Goetsch U, Gottschalk R, Günther S, Hallek M, Häussinger D, Herzog C, Jensen B, Kolibay F, Krakau M, Langebartels G, Rieger T, Schaade L, Schmidt-Chanasit J, Schömig E, Schüttfort G, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M, Wieland U, Wiesmüller G, Wolf T, Fätkenheuer G.

Euro Surveill. 2017 Sep;22(39). doi: 10.2807/1560-7917.ES.2017.22.39.17-00088.

5.

Reoccurrence of botulinum neurotoxin subtype A3 inducing food-borne botulism, Slovakia, 2015.

Mad'arová L, Dorner BG, Schaade L, Donáth V, Avdičová M, Fatkulinová M, Strhársky J, Sedliačiková I, Klement C, Dorner MB.

Euro Surveill. 2017 Aug 10;22(32). pii: 30591. doi: 10.2807/1560-7917.ES.2017.22.32.30591.

6.

[Recommendations for vaccinations in adults : Evidence and challenges of implementation].

Wichmann O, Schaade L.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Dec;59(12):1541-1543. German. No abstract available.

PMID:
27807603
7.

[On-site detection of bioterrorism-relevant agents : Rapid detection methods for viruses, bacteria and toxins - capabilities and limitations].

Stern D, Richter M, Schrick L, Lasch P, Keeren K, Polleichtner A, Lemmer K, Nitsche A, Grunow R, Herzog C, Dorner BG, Schaade L.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Dec;59(12):1577-1586. Review. German.

PMID:
27778086
8.

Infection of human airway epithelial cells by different subtypes of Dobrava-Belgrade virus reveals gene expression patterns corresponding to their virulence potential.

Witkowski PT, Bourquain D, Bankov K, Auste B, Dabrowski PW, Nitsche A, Krüger DH, Schaade L.

Virology. 2016 Jun;493:189-201. doi: 10.1016/j.virol.2016.03.018. Epub 2016 Apr 6.

9.

Comparison of the Cowpox Virus and Vaccinia Virus Mature Virion Proteome: Analysis of the Species- and Strain-Specific Proteome.

Doellinger J, Schaade L, Nitsche A.

PLoS One. 2015 Nov 10;10(11):e0141527. doi: 10.1371/journal.pone.0141527. eCollection 2015.

10.

Hantavirus-induced pathogenesis in mice with a humanized immune system.

Kobak L, Raftery MJ, Voigt S, Kühl AA, Kilic E, Kurth A, Witkowski P, Hofmann J, Nitsche A, Schaade L, Krüger DH, Schönrich G.

J Gen Virol. 2015 Jun;96(Pt 6):1258-63. doi: 10.1099/vir.0.000087. Epub 2015 Feb 12.

PMID:
25678530
11.

[Genetic information and prevention].

Tönnies H, Schaade L.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Feb;58(2):111-2. doi: 10.1007/s00103-015-2117-6. German. No abstract available.

PMID:
25585840
12.

Investigating the zoonotic origin of the West African Ebola epidemic.

Marí Saéz A, Weiss S, Nowak K, Lapeyre V, Zimmermann F, Düx A, Kühl HS, Kaba M, Regnaut S, Merkel K, Sachse A, Thiesen U, Villányi L, Boesch C, Dabrowski PW, Radonić A, Nitsche A, Leendertz SA, Petterson S, Becker S, Krähling V, Couacy-Hymann E, Akoua-Koffi C, Weber N, Schaade L, Fahr J, Borchert M, Gogarten JF, Calvignac-Spencer S, Leendertz FH.

EMBO Mol Med. 2015 Jan;7(1):17-23. doi: 10.15252/emmm.201404792.

13.

Contact investigation for imported case of Middle East respiratory syndrome, Germany.

Reuss A, Litterst A, Drosten C, Seilmaier M, Böhmer M, Graf P, Gold H, Wendtner CM, Zanuzdana A, Schaade L, Haas W, Buchholz U.

Emerg Infect Dis. 2014 Apr;20(4):620-5. doi: 10.3201/eid2004.131375.

14.

[Sexual and reproductive health: medical/scientific aspects].

Tönnies H, Schaade L.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Dec;56(12):1597-9. doi: 10.1007/s00103-013-1861-8. German. No abstract available.

PMID:
24337120
15.

Anthrax among heroin users in Europe possibly caused by same Bacillus anthracis strain since 2000.

Grunow R, Klee SR, Beyer W, George M, Grunow D, Barduhn A, Klar S, Jacob D, Elschner M, Sandven P, Kjerulf A, Jensen JS, Cai W, Zimmermann R, Schaade L.

Euro Surveill. 2013 Mar 28;18(13). pii: 20437.

16.

Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012.

Buchholz U, Müller MA, Nitsche A, Sanewski A, Wevering N, Bauer-Balci T, Bonin F, Drosten C, Schweiger B, Wolff T, Muth D, Meyer B, Buda S, Krause G, Schaade L, Haas W.

Euro Surveill. 2013 Feb 21;18(8). pii: 20406.

17.

[The 2011 HUS epidemic in Germany. Challenges for disease control: what should be improved?].

Krause G, Frank C, Gilsdorf A, Mielke M, Schaade L, Stark K, Burger R.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jan;56(1):56-66. doi: 10.1007/s00103-012-1585-1. German. Erratum in: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Aug;56(8):1153.

PMID:
23275957
18.

Protecting society. Biological security and dual-use dilemma in the life sciences--status quo and options for the future.

Uhlenhaut C, Burger R, Schaade L.

EMBO Rep. 2013 Jan;14(1):25-30. doi: 10.1038/embor.2012.195. Epub 2012 Dec 11. No abstract available.

19.

[Awareness, knowledge and responsibility].

Mielke M, Schaade L.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Nov;55(11-12):1361-2. doi: 10.1007/s00103-012-1561-9. German. No abstract available.

PMID:
23114433
20.

Lack of evidence for Schmallenberg virus infection in highly exposed persons, Germany, 2012.

Ducomble T, Wilking H, Stark K, Takla A, Askar M, Schaade L, Nitsche A, Kurth A.

Emerg Infect Dis. 2012 Aug;18(8):1333-5. doi: 10.3201/eid1808.120533.

21.

Outbreaks of virulent diarrheagenic Escherichia coli--are we in control?

Werber D, Krause G, Frank C, Fruth A, Flieger A, Mielke M, Schaade L, Stark K.

BMC Med. 2012 Feb 2;10:11. doi: 10.1186/1741-7015-10-11. Review.

22.

[Pandemic preparedness planning. What did we learn from the influenza pandemic (H1N1) 2009?].

Schaade L, Reuss A, Haas W, Krause G.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Dec;53(12):1277-82. doi: 10.1007/s00103-010-1162-4. German.

PMID:
21161478
23.

[First exchange of experiences concerning the H1N1 pandemic in Germany 2009/2010: report on a workshop held March 22-23, 2010, in Berlin].

Krause G, Gilsdorf A, Becker J, Bradt K, Dreweck C, Gärtner B, Löwer J, Marcic A, Nicoll A, Pott E, Schaade L, Schoeller A, Stollorz V, Träder C, Razum O.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 May;53(5):510-9. doi: 10.1007/s00103-010-1074-3. German.

PMID:
20437020
24.

[Vaccination recommendations of the Standing Committee on Vaccination at the Robert Koch Institute. Legal basis and significance].

Schaade L, Widders U, Stange G, Höhl N.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Nov;52(11):1006-10. doi: 10.1007/s00103-009-0955-9. German.

PMID:
19768391
25.

[Strategies for recognition, prevention and control of antimicrobial resistances in Germany - a draft from the Federal German Ministry of Health].

Barger A, Schaade L, Krause G, Kramer M.

Gesundheitswesen. 2008 Nov;70(11):631-5. doi: 10.1055/s-0028-1100392. Epub 2008 Nov 27. German.

PMID:
19039718
26.

Reactivation of the Epstein-Barr virus from viral latency by an S-adenosylhomocysteine hydrolase/14-3-3 zeta/PLA2-dependent pathway.

Maas D, Maret C, Schaade L, Scheithauer S, Ritter K, Kleines M.

Med Microbiol Immunol. 2006 Dec;195(4):217-23. Epub 2006 Jun 21.

PMID:
16944201
27.

Inflammatory pseudotumors of the central nervous system: report of 3 cases and a literature review.

Häusler M, Schaade L, Ramaekers VT, Doenges M, Heimann G, Sellhaus B.

Hum Pathol. 2003 Mar;34(3):253-62. Review.

PMID:
12673560
28.

In vitro cell free synthesis of human manganese superoxide dismutase with the RTS 500 system.

Kleines M, Nellessen M, Schaade L, Ritter K.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Mar 25;786(1-2):137-42.

PMID:
12651009
29.

Neurological complications of acute and persistent Epstein-Barr virus infection in paediatric patients.

Häusler M, Ramaekers VT, Doenges M, Schweizer K, Ritter K, Schaade L.

J Med Virol. 2002 Oct;68(2):253-63.

PMID:
12210416
30.

Encephalitis related to primary varicella-zoster virus infection in immunocompetent children.

Häusler M, Schaade L, Kemény S, Schweizer K, Schoenmackers C, Ramaekers VT.

J Neurol Sci. 2002 Mar 30;195(2):111-6.

PMID:
11897240
33.

Cloning and expression of the human single copy homologue of the mouse zinc finger protein zfr.

Kleines M, Gärtner A, Ritter K, Schaade L.

Gene. 2001 Sep 5;275(1):157-62.

PMID:
11574164
34.

Differentiation in murine mastocytoma induced by macrophage gangliosides.

Schaade L, Thomssen R, Ritter K.

Z Naturforsch C. 2000 Nov-Dec;55(11-12):1004-10.

PMID:
11204177
35.

Detection of cytomegalovirus DNA in human specimens by LightCycler PCR.

Schaade L, Kockelkorn P, Ritter K, Kleines M.

J Clin Microbiol. 2000 Nov;38(11):4006-9.

36.

Enhanced transcription of the s-adenosylhomocysteine hydrolase gene precedes Epstein-Barr virus lytic gene activation in ganglioside-stimulated lymphoma cells.

Schaade L, Kleines M, Krone B, Hausding M, Walter R, Ritter K.

Med Microbiol Immunol. 2000 Sep;189(1):13-8.

PMID:
11034553
37.
39.

Severe cytomegalovirus-triggered autoimmune hemolytic anemia complicating vertically acquired HIV infection.

Häusler M, Schaade L, Hutschenreuter G, Hannig U, Kusenbach G.

Eur J Clin Microbiol Infect Dis. 2000 Jan;19(1):57-60.

PMID:
10706183
40.
42.

Characterization of cytostatically active glycosphingolipids isolated from thioglycollate-elicited murine macrophages.

Schaade L, Ritter K, Schiebel HM, Thomssen R, Kleines M.

IUBMB Life. 1999 Sep;48(3):353-8.

43.

GB virus-C/hepatitis G virus infections in medical staff.

Schaade L, Platzer CA, Kleines M, Ritter K.

J Hosp Infect. 2000 Feb;44(2):153-4. No abstract available.

PMID:
10662569
44.

MRI follow-up of herpes simplex virus (type 1) radiculomyelitis.

Küker W, Schaade L, Ritter K, Nacimiento W.

Neurology. 1999 Mar 23;52(5):1102-3. No abstract available.

PMID:
10102445
45.

[Manganese superoxide dismutase-inhibiting autoantibodies in cholestatic Epstein-Barr viral hepatitis].

Schaade L, Meilicke R, Büttgen S, Ritter K.

Dtsch Med Wochenschr. 1998 Dec 4;123(49):1478-82. Review. German.

PMID:
9861889
46.

Supplemental Content

Loading ...
Support Center